Interviews

Christina Nguyen, senior research analyst, and Mary Beth Landrum, PhD, professor of health care policy, both at Harvard Medical School, explain why inadequate risk adjustment could counterproductively reduce payments to groups whose patient...

Jeffrey Sparks, MD, rheumatologist and population scientist, discusses the importance of high levels of physical activity and explains why he suspects physical activity has beneficial effects on the immune system and also lowers systemic...

Samy Suissa, PhD, professor of Epidemiology, Biostatistics and Medicine at McGill University in Montreal, discusses a label warning on a rheumatoid arthritis (RA) drug for patients with RA and COPD and he explains that the choice of biologic...

Joel Gelfand, MD, MSCE, professor of dermatology and epidemiology at the University of Pennsylvania, Perelman School of Medicine in Philadelphia, discusses the latest breakthroughs in managing autoimmune diseases, including psoriatic...

Chris Voigt is the chief technology officer at Privia Health, a physician practice management and population health technology company. He has more than 14 years experience in the health care interoperability field, including leading...

Kata Bognar, PhD, research economist at Precision Health Economics, discusses how rapid, cloud-enabled, onsite lab testing for RA diagnosis is valuable to payers and can potentially lower the number of visits per patient.

In this discussion, Jeffery Weinberg, MD, medical dermatologist at Mount Sinai School of Medicine, and Megan Noe, MD, MPH, dermatologist at the University of Pennsylvania, highlight the new psoriasis treatment guidelines released by NPF and...

Wendy Marder, MD, associate professor and clinical service chief of the division of rheumatology at Michigan Medicine in Ann Arbor, Michigan, discusses telemedicine in a rheumatology setting and explains how telemedicine will impact...

Ravi Vij, MD, MBA, from Washington University School of Medicine in St Louis, discusses his recent study findings that evaluated treatment sequences among patients with relapsed or refractory multiple myeloma after failure of...

James D. Chambers, PhD, MPharm, MSc, associate professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, discusses his recent study that compared FDA-required labeling with payer drug...